Project Grant R01HL173523
Award Date
9/1/24
Completion Date
6/30/28
Dollars Obligated
$1.2M
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support the development of a telemedicine intervention to improve hypertension management for Black patients. The $156,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will be used by the prime awardee, Wake Forest University Health Sciences, to tailor a telemedicine-based hypertension management...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), provides $161,000.00 to Duke University to plan a clinical trial evaluating an implicit bias mitigation training curriculum for primary care clinicians. The goal is to determine if the "Reaching Equity" training can increase use of implicit bias mitigation skills by clinicians and reduce racial disparities in hypertension...
The National Heart, Lung, and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), awarded a $874,792 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Vanderbilt University Medical Center (VUMC). The award, effective July 15, 2024 through June 30, 2028, will support research to: (1) identify new genetic variants associated with residual atherosclerotic cardiovascular disease (ASCVD) risk in patients on treatment to lower LDL-cholesterol...
This Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research, provides $815,229 to The University of Texas Southwestern Medical Center to conduct advanced research on cardiovascular disease susceptibility and resilience in Black Americans. The key objectives are to: 1) Identify proteins and protein networks associated with clinical and subclinical cardiac dysfunction, 2) Pinpoint proteins and networks linked to...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), will fund research to understand disparities in the incidence, outcomes, and post-partum care of hypertensive disorders of pregnancy (HDP). The $502,069 award to Mayo Clinic, a non-profit academic medical center, will quantify the moderating effect of socioeconomic status (SES) on the relationship between urban/rural status and HDP. The research...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under CFDA 93.837 - Cardiovascular Diseases Research provides $130,065 in funding to The Regents of the University of California, San Francisco (UCSF) to conduct research and mentorship activities focused on optimizing the treatment and evaluation of blood pressure for patients in safety net health systems. The key objectives are to: 1) Conduct systematic economic analyses of the costs associated with...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $786,060 to Vanderbilt University Medical Center to study how hypertension induces "trained immunity" in myeloid cells, potentially contributing to chronic inflammation and increased risk of atherosclerotic cardiovascular disease. The research aims to determine how hypertension rewires the epigenome of myeloid progenitors, leading...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $2,709,341.45 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Trustees of Columbia University in the City of New York to conduct a 1-week daily diary study. The study aims to estimate the influence of intersectional anticipated and vicarious stigma on home blood pressure, and examine potential mediating mechanisms such as salivary stress biomarkers and anxiety. The research will recruit a...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,000 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of Connecticut. The grant will fund a 12-week proof-of-concept study testing a technology-delivered mindful walking intervention to reduce stress, increase physical activity, and lower blood pressure in Black women with hypertension. The project aims to address disparities in hypertension and physical activity rates among...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), aims to pilot test the effectiveness of a culturally tailored virtual reality (VR)-based stress management program in addressing intersectional stress and improving cardiovascular health outcomes among hypertensive Black women. The University of Miami will receive $165,807 over a 5-year period starting August 1, 2024 to conduct focus...